Millstone Medical Outsourcing, the industry's leading partner of choice for medical manufacturers' post-manufacturing and aftermarket services, announces that it will move its testing services division to an upgraded, expanded 25,000-square-foot facility in Bloomfield, Connecticut. The move represents a 400% increase in service capacity and is anticipated to be operational early in Q2 2024.
Growth in Millstone's Testing Services
Millstone Medical Outsourcing launched its testing service offering in December 2022 after the acquisition of contract testing organizations Ethide Laboratories and MycoScience. The acquisition brought 90 years of combined experience in advanced microbiology laboratory and environmental testing services to support customers.
Customers will benefit from the state-of-the-art upgrades to the laboratory facilities and renovated lab space. Facility upgrades include a world-class BI sterility suite to support EO sterilization validations. With the facility relocation and expansion, Millstone plans to introduce new testing services. These include manual and automatic reusable instrument cleaning validations and package testing services focused on shipping distribution simulation, as well as new analytic chemical tests such as total organic carbon testing. Testing services will continue to expand with additional offerings in 2024 and beyond.
"Millstone focuses on helping our customers deliver lifesaving and life-changing products," CEO Karl Neuberger said. "Our ability to provide industry-leading turnaround times and exceptional customer service is essential to this mission. Millstone's testing services have flourished since the launch one year ago, and this move enables us to expand our offerings and serve more OEM customers. In addition, relocating to the Hartford area will bring jobs to the region as well as simplify customer travel."
Comments powered by CComment